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ABSTRACT
Current surgical procedures to treat osteoarthritis have varying degrees of success,
but carry inherent risks and a finite life expectancy. A more permanent solution is a
treatment that regenerates biologically viable tissue that integrates with the patient and
retains functionality. For maximal effectiveness, such a treatment should also repair bone
loss known to occur in osteoarthritis and attenuate chronic inflammation that can obstruct
healing. Mesenchymal stem cells have great potential to be used as part of a novel
therapy for bone and cartilage regeneration. They are a highly regulated, self-renewing
population of cells with potent mechanisms to avoid allogeneic rejection, offering
significant potential for the generation of tissue that can replace damaged areas in the
body with minimal risk of side effects. In order to realize this potential, it is important to
take advantage of the mechanisms that induce stem cell differentiation into desired
tissues or structures, and enhance the qualitative extent of stem cell proliferation and
differentiation, all while mitigating the effects of inflammation. Studies have shown that
temperature is strongly correlated with reparative processes in tissue. Mild heat shock has
been shown to induce proliferation and differentiation of osteoprogenitor cells in vitro.
The central hypothesis of our study is that mild heat shock may facilitate the bone and
cartilage regeneration from MSCs under inflammatory conditions of osteoarthritis. In this
study we focus on the osteocentric model of osteoarthritis and investigate the direct
effects of mild heat shock on the osteogenic differentiation of hMSCs while simulating
inflammation. Human MSCs isolated from bone marrow were seeded in 2D culture plates
and incubated for 1 hour at 39°C once per week during osteogenic differentiation.
Alkaline phosphatase activity was downregulated by periodic heating at Day 6 of
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differentiation. Heat shock had little effect on calcium deposition at Day 19, but it did
have a cytokine-dependent effect at Day 28 – increasing calcium deposition in MSC
cultures with IL-6 and decreasing calcium deposition in MSC cultures with TNF-α.
Periodic heat shock also induced proliferation of MSCs at Day 6 and mitigated TNF-αinduced apoptosis. These results demonstrate that mild hyperthermia may potentially be
used to facilitate bone regeneration in osteoarthritis using hMSCs, and therefore may
influence the design of heat-based therapies to be used in vivo.
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I. INTRODUCTION
Osteoarthritis (OA) is the leading cause of chronic disabilities, affecting millions
of people annually1. The cost of treating arthritis and related conditions in the U.S. is over
65 billion dollars a year, making OA a heavy disease burden. Though not directly caused
by aging, osteoarthritis has become inevitable even with aging, contradicting the
increasing demand of the elderly population to retain a physically active lifestyle. Precise
mechanisms of the pathological changes associated with OA are not clearly understood,
yet physicians are still responsible for managing the symptoms of OA. Compounding the
issue are the costly and impermanent treatments currently available for OA. A minimally
invasive and simple therapy for OA would be a promising approach in bone and cartilage
regenerative medicine, and a heat-based therapy may be such an approach. By studying
the effect of heat on the osteogenic differentiation of human mesenchymal stem cells
during inflammation, we may facilitate the development of a thermotherapy for OA.

1. Clinical Significance of Osteoarthritis
Osteoarthritis is characterized by the structural breakdown of the synovial joint.
Articular cartilage is largely devoid of nerve supply, so early cartilage degradation as a
result of OA may not be detected as pain. Once damaged, articular cartilage has limited
repair and regeneration potential. This is due to a number of reasons. The sparse numbers
of mature chondrocytes in adult articular cartilage are mainly engaged in matrix
maintenance rather than active progenitor cells capable of rapid proliferation2. And
because cartilage lacks a blood supply, deposition of new matrix is slow. Additionally,
chondrocytes are immobilized in lacunae preventing them from migrating to damaged
areas. In contrast, bone tissue contains progenitor cells or stem cells that are either
1

resident, or readily capable of arriving via the blood supply3. Interestingly, the presence
of angiogenesis in cartilage induces ossification from the same mesenchymal stem cells
that are capable of chondrogenic differentiation in the absence of vascularization3,
indicating that repair of serious synovial joint lesions is not possible without delivery of
tissue forming cells. Thus, the primary cause for the poor regenerative capability or
articular cartilage is the lack of a sufficient number of chondrogenic cells.
Though the most commonly associated symptom of OA is the degradation of
articular cartilage, it would be inaccurate to consider OA as a disease of cartilage alone.
Chondrocentric and osteocentric models still exist, but OA should be considered as a
disease of the entire joint, to which changes in cartilage, bone, bone marrow, synovium,
menisci, ligaments, and neural tissue contribute5,6. Changes to the condition of the
subchondral bone, including attrition or loss of bone, are common in persons with
advanced OA, and evidence suggests that the subchondral bone is important for both
generation of pain and progression of OA7. Indeed, bone and cartilage health are tightly
associated. Because early cartilage degradation may not be detected as pain, patients
often do not seek care until more severe osteochondral lesions have formed. Upon
formation of osteochondral lesions, repair of the synovial joint condyle becomes a task of
regenerating an organ consisting of both articular cartilage and subchondral bone, instead
of regenerating simply the articular cartilage. Bone attrition is a distinct dimension of OA
severity, different from osteophyte formation and joint space narrowing, but it is
uncommon in individuals with less advanced disease8. In light of these facts, some
researchers believe that subchondral bone should be the main target for treatment of
osteoarthritis9. A comprehensive, systems biology approach is necessary to identify
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windows of opportunity for targeted treatments to regenerate both bone and cartilage in
late stage OA. Such an approach would be promising in bone and cartilage regenerative
medicine.

2. Current Treatments for Osteoarthritis
Exercise and analgesics are the mainstay of treatment for OA. Moderate exercise
leads to improved functioning and decreased pain in people with OA of the knee10.
Various surgical procedures and interventions are used to relieve pain and restore joint
function, but all current therapies yield mixed results. Minimal procedures include
lavage, shaving, laser abrasion, and debridement, where the surgeon arthroscopically
removes loose cartilage causing bleeding at the bone surface and the growth of
fibrocartilage. Microfracture is a similar technique where the surgeon arthroscopically
makes perforations in the bone to stimulate bleeding and growth of fibrocartilage, but
fibrocartilage may not be strong enough to withstand the loads on some joints. A more
invasive surgical procedure is autologous chondrocyte implantation where the surgeon
harvests a small portion of articular cartilage from the host, sends it to a lab to be
cultured, and implants the lab-grown cells at the site of damaged cartilage in a second
surgery11. Alternatively, the sample cartilage to be cultured can be taken from a human
donor or an animal2. Mosaicplasty is a similar procedure where a plug of bone covered
with cartilage is removed from a healthy area of the joint and transplanted to the damaged
area. These therapies, though successful in varying degrees in treating articular defects,
are only designed for localized joint lesions of limited size. For severe osteochondral
lesions, the drastic procedure of total joint replacement using a metallic condyle in a
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polyethylene socket is common practice, but it suffers from drawbacks such as donor site
morbidity, pathogen transmission, wear and tear, and a limited lifespan12. Secondary
surgeries are necessary in 10-15% of the cases and suffer from substantial difficulties
such as scar tissue formation and loss of host tissue14. Furthermore, the limited
availability of donor tissue remains an issue as does their intrinsic tendency to lose their
phenotype during expansion14. More importantly, these treatment modalities do not lead
to biological regeneration. The permanent solution that clinicians and scientists aspire to
would be the regeneration of a biologically viable synovial joint condyle that is capable
of integrating with the patient and remains functional throughout the patient’s lifetime.

2. Inflammation and the Role of Cytokines
Inflammation is commonly associated with rheumatoid arthritis, psoriatic arthritis,
and other types of inflammatory arthritis. OA on the other hand is usually explained as
“wear and tear” arthritis, meaning that it is related to aging and changes in the cartilage.
While pain is common in OA, inflammation is usually associated with other types of
arthritis. However, as OA progresses inflammation can occur around an affected joint. It
was thought that the inflammation is caused by cartilage fragments that break off and
irritate the synovium. However, MRIs taken during the early stages of osteoarthritis
sometimes detect synovitis (inflammation of the joint lining) even though the joint
cartilage still appears normal. This indicates that other joint structures also may be
involved in triggering inflammation15.
Other factors involved may come from the complex network of biochemical
factors, including proteolytic enzymes that lead to a breakdown of the cartilage
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macromolecules. Pro-inflammatory cytokines such as interleukin-1 (IL-1) and tumor
necrosis factor alpha (TNF-α) produced by activated synoviocytes, mononuclear cells, or
by articular cartilage itself significantly upregulate metalloproteinase gene expression.
Cytokines also blunt chondrocyte compensatory synthesis pathways required to restore
the integrity of the degraded extracellular matrix (ECM). Moreover, in OA synovium, a
relative deficit could possibly be related to an excess production of nitric oxide in OA
tissues. This coupled with an upregulation in the receptor level, has been shown to be an
additional enhancer of the catabolic effect of IL-1 in this disease16.
Most cytokines promote inflammation, and these cytokines are responsible for the
maintenance of chronic inflammation, which can result in tissue destruction rather than
tissue repair. Pro-inflammatory cytokines appear to alter the metabolism of cells from
synovial joints. Production of cytokines such as interleukin-6 (IL-6) and TNF-α in the
synovial membrane is generally considered to promote pathological OA17,18,19. They have
been reported to contribute to OA pathogenesis by increasing cartilage degradation and
inducing hyperalgesia (increased sensitivity to pain) through various direct and indirect
actions. TNF-α promotes reduced bone formation by mature osteoblasts, increased
osteoclastic resorption, and inhibits differentiation of osteoblasts from precursor cells20. It
has also been shown to inhibit the synthesis of type I collagen and induction of osteoblast
resistance to vitamin D21,22,23,24,25,26,27,28. This shift in the formation-resorption balance in
the skeleton toward resorption leads to periarticular bone loss in inflammatory arthritis.
TNF-α dose dependently inhibits differentiation of osteoblasts from their precursor cells
and inhibition of expression of the osteocalcin gene. Low doses are able to inhibit
differentiation, indicating that osteoblast precursors are sensitive to TNF-α.
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IL-6 is reported to have a more complex role in OA pathogenesis by initiating
inflammatory responses such as the production of tissue inhibitors of metalloproteinase,
and this may act to limit cartilage damage via negative feedback29, while TNF-α is related
to synovitis30,31,32,33. A recent study suggested that IL-6 production might be increased in
the early stage of joint destruction in OA patients34. Other studies have reported that
TNF-α induced IL-6 upregulation, and thus IL-6 may still contribute to OA
progression35,36,37. Because of their significant role in OA pathogenesis, potential clinical
therapies for OA must be shown to be effective at mitigating the effects of proinflammatory cytokines.

3. Potential of Mesenchymal Stem Cells in Osteochondral Regeneration
Human mesenchymal stem cells (hMSCs) can differentiate into a variety of cell
types including osteoblasts, adipocytes, chondrocytes, and endothelial-like cells38,39. The
ease with which they can be isolated and expanded and their ability to differentiate along
multiple connective tissue lineages have made them the cell type of choice for
osteochondral tissue engineering. In order to advance the therapeutic use of MSCs it is
crucial to find ways to enhance the qualitative extent of differentiation, maximizing the
probability of the cells to differentiate and grow into the desired tissue or structure. In this
way, MSCs have the potential to do what metallic implants cannot: create a biologically
viable structure that retains functionality in the patient.
Intensive studies have been done on the influences of growth factors40,
cytokines41, and mechanical loading42 on MSC differentiation into osteoblasts, but these
osteoblasts are not as functionally mature as primary adult cells. Likewise, the properties
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of MSC-derived chondrocytes remain lower than those of native tissue43. The successful
application of MSC-based osteochondral tissue engineering ultimately depends on the
able differentiation of stem cells into articular chondrocytes and mature osteoblasts as
well as the assembly of the appropriate cartilaginous matrix to achieve the load bearing
capabilities of the natural articular cartilage. Multiple requirements including growth
factors, signaling molecules, and physical influences, need to be met.

3. Potential of Thermotherapy
Because OA can only be managed by artificial joint replacement when joint
destruction becomes severe, it is preferable to administer a therapy that is easy, simple,
and effective in inhibiting OA progression at the early stage. Temperature may be
approach to a therapy that both regulates MSC differentiation and controls inflammation
and is also easily administered. It is known that Hsp70, a protein synthesized in cells
under duress, has a protective effect on the cartilage and inhibits the apoptosis of the
chondrocytes44 (Fig. 1).

Figure 1. Hsp70 protects cartilage and inhibits apoptosis of chondrocytes and increases cartilage
metabolism, potentially slowing the progression of OA.
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Heat stimulation of the joints by microwave increases Hsp70 expression in
chondrocytes44. Hsp70 also enhances matrix metabolism of the cartilage44. These findings
suggest that hyperthermia can be positively applied to the treatment of OA.
Thermotherapy is widely used for musculoskeletal diseases45. It has been shown
to promote bone repair after injury in vivo46. By promoting blood supply, heat may
influence bone metabolism and accelerate bone formation47. Studies have indicated that
heat stimulates proliferation, alkaline phosphatase activity, and mineralization in human
mesenchymal stem cells48, the latter two being markers of osteogenic differentiation. A
heat-based treatment of OA thus has potential to repair bone and cartilage attrition in OA.
However, no in vitro experiments have been conducted which demonstrate how heat may
promote cell proliferation and perhaps facilitate tissue regeneration in the inflammatory
environment. Additionally, the intensity and duration of heat stimulation used for
hyperthermia are empirically determined, and its effect has not been scientifically proven.
In order to effectively use hyperthermia in future therapies, it is necessary to determine its
effect on MSC growth and differentiation as well as the optimal intensity and duration of
heat stimulation in humans.
In this study, we focus on the osteocentric model of OA. Human mesenchymal
stem cells (hMSCs) are osteogenically differentiated while simulating inflammation in
osteoarthritis by exposing cultures to TNF-α and IL-6. Two different concentrations of
each are used. High-dose concentrations (1ng/mL TNF-α, 20ng/mL IL-6) were chosen
based on previous studies involving in vitro culture of MSCs with IL-6 and TNFα49,50,51,52. Low-dose concentrations (4pg/mL TNF-α, 20ng/mL IL-6) were chosen based
on concentrations of cytokines found in the synovial fluid of knee joints in patients with
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OA34. Cell cultures are then exposed to periodic mild heating, 39°C for 1 hour once per
week. The heating temperature was chosen based on body temperature during exercise66.
Mild hyperthermia may enhance osteogenesis of MSCs and mitigate inflammation.
Osteogenesis was measured by alkaline phosphatase activity and calcium deposition.
Results of this study would validate a suitable heating protocol for MSC osteogenesis and
benefit further investigations toward using thermal treatments for OA.

9
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II. MATERIALS AND METHODS
1. Human Mesenchymal Stem Cell Isolation and Culture
Human bone marrow explanted from the iliac crest of a 24-year old donor was
purchased from AllCells, LLC (Berkeley, CA). Human mesenchymal stem cells were
enriched using the RosetteSep MSC enrichment cocktail (StemCell Technologies,
Vancouver, Canada) according to manufacturer’s protocol and expanded in tissue culture
flasks with MSC growth medium consisting of Dulbecco’s modified Eagle’s medium low glucose, 10% fetal bovine serum (FBS) (Atlanta Biologicals, Lawrenceville, GA),
and 1% penicillin-streptomycin (Invitrogen, Carlsbad, CA) then incubated at 37°C and
5% CO2.
Fluorescence-activated cell sorting (FACS) analysis was performed on the hMSCs
using a FACSCalibur flow cytometer (BD Biosciences) and tested positive for surface
markers CD146, CD44, CD29, and CD147 and negative for hematopoietic cell markers
CD45 and CD34.
Human MSCs were subcultured at a density of 5000 cells/cm2 with biweekly media
changes, and then seeded at passage 4 in 24-well plates at the same density in 0.5mL
MSC growth medium per well. Media was replaced with growth media containing
experimental concentrations of IL-6 (300pg/mL, 20ng/mL) and TNF-α (4pg/mL,
1ng/mL) the day after seeding to simulate inflammation. Osteogenic differentiation was
induced the following day (Day 0) with osteogenic medium consisting of MSC growth
medium supplemented with 50μM ascorbic acid phosphate (AsAP) (Wako Chemicals
USA, Richmond, VA), 0.1μM dexamethasone, and 10mM β-glycerol phosphate. Media
was changed biweekly.
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2. Heat Exposure
Human MSCs were exposed to mild heat shock (HS) at 39°C for 1 hour once per
week on Day 2, 9, 16, and 23. The heating incubator was pre-calibrated with an accuracy
of ±0.2°C. Media was changed after heating to account for evaporation then returned to
37°C. Control cell cultures remained in 37°C with concurrent media changes.

3. Differentiation and Visualization of Mineralized Nodules
Morphology changes of the hMSCs in different culture conditions were observed by
phase microscopy using a Zeiss Axio Observer Z1 inverted microscope. Von Kossa
staining was used to visualize mineralization on Day 28. Briefly, hMSCs were rinsed
with Tyrode’s balanced salt solution, fixed with 10% buffered formalin (Fisher Scientific,
Pittsburgh, PA) for 30 min, incubated with 5% silver nitrate for 10 mins in the dark,
rinsed with ddH2O, and exposed to light for 1 hour. Brightfield images of stained samples
were captured with a Zeiss Axiovert 40 CFL inverted microscope.

4. Alkaline Phosphatase Activity
Alkaline phosphatase (ALP) activity was quantified using a colormetric assay
using p-nitrophenol on Day 6 and 12. Medium was removed from MSCs and the cells
washed twice with PBS then lysed with 0.5% Triton X-100 lysis buffer (Bio-Rad
Laboratories, Hercules, CA). They are then incubated with 500 L of alkaline buffer
solution and 500 L of ALP substrate solution (alkaline buffer solution containing 5mM
p-nitrophenol phosphate) for 15 min at 37 C. Specific ALP activity (expressed as
nanomoles of PNP/mL/min/ng DNA) was measured at 405nm using a SpectraMax M2e
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microplate reader (Molecular Devices, Silicon Valley, CA) and quantified against a
standard curve of p-nitrophenol.

5. Mineralization
Calcium levels were determined using the StanBio Total Calcium Procedure
(Fisher Chemical Co., Los Angeles, CA) on Day 19 and 28. Medium was removed from
MSCs and the cells washed twice with PBS then lysed using a solution of 0.5N HCl in
distilled water. Three microliters of lysate was added to a 96-well plate with 300μL of
provided color reagent, then read at 550nm using a SpectraMax M2e microplate reader
and quantified against a standard curve.

6. DNA Content
The cell lysates prepared for ALP assay were measured for DNA content using the
Quant-iT™ PicoGreen ® dsDNA Reagent kit (Invitrogen, Carlsbad, CA). Parallel cell
cultures were lysed on Day 19 and 28 using 0.5% Triton X-100 lysis buffer. Briefly, 75μL
of 13.22 mg/mL pepsin in 0.05N acetic acid was added to 300μL of cell lysate and
incubated at 2-8°C for 24 hours in order to digest excess protein in the lysate. The pepsin
was neutralized with 75μL of pH=8.0 Tris buffer following the incubation period. After
pelleting cell debris in the lysates, 20μL of the suspension was added to a 96-well plate
with 80μL assay buffer and 100μL of PicoGreen fluorescent dye solution. The plate was
incubated away from light for 10 mins and then read on a SpectraMax M2e reader at
excitation of 480nm and emission of 520nm. DNA content was quantified using a known
amount of DNA as the standard.
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7. Statistical Analysis
All values were expressed as mean ± standard deviation and statistically analyzed
using a two-tailed Student’s t-test. For all comparisons, the level of significance was p ≤
0.05.
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III. RESULTS
1. Expression of Surface Markers in Isolated hMSCs
In Figure 2, flow cytometric analysis shows that passage 4 of isolated hMSCs was
over 80% positive for surface markers of CD44 (hyaluronan receptor), CD29 (integrin
B1), and CD147 (extracellular matrix metalloproteinase inducer), slightly positive for
CD146 (melanoma cell adhesion molecule), and more than 90% negative for CD45
(leukocyte common antigen) and CD34 (lipopolysaccharide receptor), CD34 and CD45
being surface markers of the hematopoietic lineage and CD146 being the surface marker
of endothelial cell lineage, an epitope suggested as a biomarker for MSCs.

Figure 2. Flow cytometric analysis of hMSCs isolated from 24-year old donor.

2. DNA Content
MSCs that had been heat shocked at 39°C for 1h once a week had significantly higher
DNA content than MSCs cultured at 37°C (control) at Day 6 in all media conditions
except for osteogenic control which was statistically unchanged after heat shock (p =
0.4025). MSCs cultured with TNF-α (Fig. 3, orange and purple lines) had significantly
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lower DNA content than both MSCs cultured in IL-6 and control cultures (no cytokines)
(p < 0.0138), but DNA content is markedly higher at Day 6 after heat exposure (p <
0.0185). There was no statistical difference in DNA content between high and low doses
of IL-6 and TNF-α at Day 6.
MSCs in all conditions continued to proliferate to Day 12. MSCs cultured with lowdose IL-6 (300pg/mL) in normal growth media (Figs. 3A and 3B, red line) along with
both control conditions (Fig. 3, blue lines) had higher DNA content following heat shock
(p < 0.0459), though this was a smaller increase compared to Day 6. In all other culture
conditions, DNA content was statistically identical following heat shock at Day 12.
MSCs cultured with TNF-α again had significantly lower DNA content compared to
cultures containing IL-6 and controls. There was no statistical difference in DNA content
between high and low doses of IL-6 and TNF-α at Day 12.
DNA content significantly decreased in control cultures and cultures with IL-6 at Day
19. In contrast, MSCs cultured with TNF-α continued to proliferate to Day 19.
Additionally, DNA content in cultures containing TNF-α was statistically identical to
controls at 37°C, but higher than controls in heat shocked cultures (p < 0.0238).
Interestingly, there was no statistically significant change in DNA content in each culture
condition following heat shock. There was also no statistical difference in DNA content
between high and low doses of IL-6 and TNF-α at Day 19.
DNA content significantly decreased in all culture conditions at the final time point,
Day 28. MSCs cultured with high-dose TNF-α (1ng/mL) (Fig. 3, orange lines) were
found to have lower DNA content following heat shock in both normal growth (p =
0.0259) and osteogenic media (p = 0.0395). MSCs cultured with low-dose IL-6 and
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MSCs cultured with high-dose IL-6 had significantly higher DNA content in osteogenic
media following heat shock (p < 0.015) at Day 28. There was no statistical difference in
DNA content between high and low doses of IL-6 and TNF-α at Day 28, with the
exception of the TNF-α group in normal growth media which had lower DNA content in
the high-dose culture (p = 0.0092).

Figure 3. Effect of heat and cytokines on proliferation of MSCs as measured by DNA content. A)
MSCs in normal growth media at 37°C, B) MSCs in growth media and heat shocked, C) MSCs in
osteogenic media at 37°C, D) MSCs in osteogenic media and heat shocked. Error bars denote standard
deviation.

3. Morphological Appearance of MSCs During Osteogenic Differentiation
Phase contrast images in Figures 4 and 5 show that hMSCs undergo significant
changes in morphology during expansion in culture in osteogenic medium compared to
control. Cells lose their spindle-like morphology as they differentiate down an osteogenic
pathway whereas cell cultures in normal growth media retain their typical fibroblastic
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appearance throughout the entire 28 days of culture. Mineralization is visibly higher in
osteogenic cultures compared to controls. MSCs exposed to TNF-α also showed more
mineralization than MSCs exposed to IL-6 or controls (Figure 5).
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Day 12

Day 19

Day 28

Heated OS
IL-6

Heated OS
control

OS IL-6

OS control

Heated IL-6

Heated
control

IL-6

Control

Day 6

Figure 4. hMSC morphology and mineralization following exposure to IL-6 and heat. The cultured MSCs
exhibited typical fibroblastic morphology in normal growth media compared to the distinct morphology in
osteogenic media (OS). Images from high-dose groups are shown.
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Day 12

Day 19

Day 28

Heated OS
TNF-α

Heated OS
control

OS TNF-α

OS control

-

Heated TNF α

Heated
control

TNF-α

Control

Day 6

Figure 5. hMSC morphology and mineralization following exposure to TNF-α and heat. TNF-α appears to
induce more mineralization compared to IL-6 or controls regardless of heat. Images from high-dose groups
are shown.
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4. Characterization of Osteogenic Differentiation
Von Kossa staining was used to qualify the level of mineralization within the different
experimental groups, which in turn is an indicator of the degree of osteogenic
differentiation. Figures 6 and 7 clearly show that osteogenic media resulted in
significantly deeper intensity of Von Kossa staining indicating enhanced mineralization.
Brightfield images of osteogenic cultures sharply contrast with those of normal growth
media which had little to no intensity. There are, however, two notable exceptions - the
high-dose IL-6 group in normal growth media kept at 37°C (Fig. 6) and the high-dose
TNF-α group periodically heat shocked (Fig. 7). These cultures had higher Von Kossa
stain intensity than any other in normal growth media.
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300pg/mL IL-6

20ng/mL IL-6

Heated OS

OS media

Heated control

Control media

Control

Figure 6. Von Kossa staining after 28 days of culturing MSCs in normal growth media (control) and
osteogenic media both containing IL-6.
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4pg/mL TNF-α

1ng/mL TNF-α

Heated OS

OS media

Heated control

Control media

Control

Figure 7. Von Kossa staining after 28 days of culturing MSCs in normal growth media (control) and
osteogenic media containing TNF-α.

5. Alkaline Phosphatase Activity
Alkaline phosphatase (ALP) activity is one marker of early stage osteogenic
differentiation. ALP activity was significantly higher in osteogenic cultures than in
cultures grown in normal growth media at Day 6 (Fig. 8). Within the control media
group, ALP activity by MSCs exposed to low-dose TNF-α (4pg/mL) and the control (no
cytokines) increased following heat shock (p < 0.002). All other conditions remained
statistically unchanged after heat shock. ALP activity by MSCs exposed to high-dose
TNF-α (1ng/mL) was significantly higher than the low-dose (p < 0.0031) which in turn
23

was higher than the control (p < 0.0184) in both osteogenic and normal growth media
regardless of heat. ALP values of MSCs cultured with IL-6 (both high and low doses)
were higher compared to controls in all conditions (p < 0.0152), but were statistically
identical to each other.

Figure 8. Colormetric assay for alkaline phosphatase measured at 6 days. A) MSCs exposed to IL-6
incubated at 37°C, B) MSCs exposed to IL-6 and heat shocked, C) MSCs exposed to TNF-α incubated
at 37°C, D) MSCs exposed to TNF-α and heat shocked. Error bars denote standard deviation.

Alkaline phosphatase activity was still higher in osteogenic cultures compared to
normal growth media at Day 12 (Fig. 9). ALP activity by MSCs cultured in osteogenic
media and exposed to low-dose TNF-α increased following heat shock (p < 0.0167). All
other conditions remained statistically unchanged after heat shock. ALP activity by MSCs
exposed to high-dose TNF-α was significantly higher than the low-dose and the control in
both osteogenic and normal growth media regardless of heat (p < 0.0071), but ALP
activity in low-dose cultures were statistically identical to controls. ALP values of MSCs
cultured with IL-6 (both high and low doses) were higher compared to controls in all
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conditions (p < 0.0485), but there was no difference in ALP activity between low and
high-dose cultures.
Figure 10 depicts the same data as a function of time. ALP activity significantly
increased in MSCs cultured in growth media from 6 to 12 days regardless of heat (p <
0.0013). Activity decreases in MSCs cultured in osteogenic medium from 6 to 12 days
also regardless of heat (p < 0.0214), the only exception being the heated osteogenic
control group (p = 0.0509).

Figure 9. Colormetric assay for alkaline phosphatase measured at 12 days. A) MSCs exposed to
IL-6 incubated at 37°C, B) MSCs exposed to IL-6 and heat shocked, C) MSCs exposed to TNF-α
incubated at 37°C, D) MSCs exposed to TNF-α and heat shocked. Error bars denote standard
deviation.
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Figure 10. Colormetric assay for alkaline phosphatase measured at 6 and 12 days. A) MSCs
cultured in normal growth media at 37°C, B) MSCs cultured in growth media and heat shocked,
C) MSCs cultured in osteogenic media at 37°C, D) MSCs cultured in osteogenic media and heat
shocked. Error bars denote standard deviation.

After normalizing the ALP data to DNA content, ALP activity in MSCs cultured in
osteogenic media remain higher than those cultured in normal growth media at Day 6;
however, ALP activity significantly decreases in all conditions following heat shock (p <
0.0168) (Fig. 11). ALP activity in MSCs exposed to high-dose TNF-α was significantly
higher than low-dose (p < 0.0071) which in turn was higher than the control (p < 0.001)
in both osteogenic and normal growth media regardless of heat. ALP values of MSCs
cultured with low-dose IL-6 were higher compared to controls in all conditions (p <
0.0387), but there was no difference in ALP activity between low and high-dose cultures
except for the osteogenic control (no heat) where high-dose values were lower than lowdose values (p = 0.0057).
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Figure 11. Colormetric assay for alkaline phosphatase measured at 6 days, normalized to DNA
content. A) MSCs exposed to IL-6 incubated at 37°C, B) MSCs exposed to IL-6 and heat shocked,
C) MSCs exposed to TNF-α incubated at 37°C, D) MSCs exposed to TNF-α and heat shocked.
Error bars denote standard deviation.

At Day 12, after normalizing the data to DNA content, the effects of heat shock are
relatively marginal (Fig. 12). ALP activity in MSCs cultured in osteogenic media is again
higher than those cultured in normal growth media. There is a slight increase in ALP
activity found to be statistically significant (p < 0.0248) in the low-dose TNF-α group
following heat shock in both osteogenic and normal growth media. In contrast, there is a
slight decrease in ALP activity in the low-dose IL-6 group in normal growth media
following heat shock (p = 0.0165). There is also a slight decrease in ALP activity in the
osteogenic control group following heat shock (p = 0.0165). ALP activity by MSCs
exposed to high-dose TNF-α was significantly higher than low-dose (p < 0.0411) which
in turn was higher than the control (p < 0.0021) in both osteogenic and normal growth
media regardless of heat. ALP values of MSCs cultured with IL-6 (both low and highdose) were higher compared to controls in osteogenic media (p < 0.0256), but there was
27

no difference in ALP activity between low and high-dose IL-6 groups in either media.

Figure 12. Colormetric assay for alkaline phosphatase measured at 12 days, normalized to DNA
content. A) MSCs exposed to IL-6 incubated at 37°C, B) MSCs exposed to IL-6 and heat shocked,
C) MSCs exposed to TNF-α incubated at 37°C, D) MSCs exposed to TNF-α and heat shocked.
Error bars denote standard deviation.

Rearranging the normalized data as a function of time, ALP activity was shown to
have significantly increased in IL-6 and control groups in normal growth media from 6 to
12 days (p < 0.0011) while there was no statistically significant difference in the TNF-α
groups during the same time (Fig. 13A). Following heat shock, all growth media groups
had significantly increased ALP activity (p < 0.0019). There was a significant decrease in
ALP activity in all MSCs cultured in osteogenic media from 6 to 12 days (p < 0.0019),
though the values were significantly lower following heat shock at Day 6.
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Figure 13. Colormetric assay for alkaline phosphatase measured at 6 and 12 days, normalized to
DNA content. A) MSCs cultured in normal growth media at 37°C, B) MSCs cultured in growth
media and heat shocked, C) MSCs cultured in osteogenic media at 37°C, D) MSCs cultured in
osteogenic media and heat shocked. Error bars denote standard deviation.

6. Calcium Deposition
Calcium deposition was used as an indicator of late stage osteogenesis and maturation
of osteoblasts differentiated from MSCs. As shown in Figure 14, calcium deposition in
the osteogenic group was higher than the control group after 19 days in all culture
conditions. However, there is a significant decrease in calcium in both the control groups
(p < 0.044) and the low-dose TNF-α group (p < 0.0232) following heat treatment (Fig.
14B, 14D). Calcium deposition was higher in MSCs exposed to low and high-dose TNFα compared to controls in osteogenic media (p < 0.0404), but statistically indifferent
between the two. Calcium was also found to be significantly higher in the high-dose
TNF-α group compared to controls and the low-dose cultures in normal growth media (p
< 0.0255) (Fig. 14C, 14D).
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Figure 14. Colormetric assay for calcium measured at 19 days. A) MSCs exposed to IL-6 incubated at
37°C, B) MSCs exposed to IL-6 and heat shocked, C) MSCs exposed to TNF-α incubated at 37°C, D)
MSCs exposed to TNF-α and heat shocked. Error bars denote standard deviation.

At Day 28, calcium deposition in the osteogenic group was again higher than the
control group (Fig. 15). Calcium was lower in the high-dose TNF-α group in osteogenic
media following heat shock (p = 0.0007) (Fig. 15D), but there was no statistical
difference in calcium content in all other conditions following heat shock. On the other
hand, calcium was higher in the high-dose TNF-α osteogenic culture at 37°C compared to
control (no cytokines) (p = 0.0289) (Fig. 15C). In the IL-6 group, calcium was lower in
the high-dose heated osteogenic condition compared to heated control (p = 0.0041) (Fig.
15B).
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Figure 15. Colormetric assay for calcium measured at 28 days. A) MSCs exposed to IL-6 incubated at
37°C, B) MSCs exposed to IL-6 and heat shocked, C) MSCs exposed to TNF-α incubated at 37°C, D)
MSCs exposed to TNF-α and heat shocked. Error bars denote standard deviation.

Figure 16 depicts the same data as a function of time. Calcium content significantly
decreased from 19 to 28 days in normal growth media (p < 0.0102) (Fig. 16A, 16B).
There was no significant change in the low-dose TNF-α group in normal growth media
during that time. Calcium deposition was much higher in all osteogenic groups,
regardless of exposure to cytokines (p < 0.0023) (Fig. 16C, 16D).
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Figure 16. Colormetric assay for calcium measured at 19 and 28 days. A) MSCs cultured in normal
growth media at 37°C, B) MSCs cultured in growth media and heat shocked, C) MSCs cultured in
osteogenic media at 37°C, D) MSCs cultured in osteogenic media and heat shocked. Error bars denote
standard deviation.

After normalizing the calcium data to DNA content, calcium deposition remains
significantly higher in the osteogenic groups compared to normal growth media at Day
19. There is a significant decrease in calcium in the control groups as well as the low
dose TNF-α group in normal growth media following heat shock (p < 0.0239) (Fig. 17B,
13D). Calcium deposition by MSCs exposed to high-dose TNF-α was significantly higher
than low-dose (p < 0.0003) which was lower than the control (p < 0.0089) in normal
growth media regardless of heat. Additionally, calcium deposition of MSCs exposed to
low-dose TNF-α were statistically significantly higher compared to controls in osteogenic
media regardless of heat (p < 0.0292) (Fig. 17C, 17D).
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Figure 17. Colormetric assay for calcium measured at 19 days, normalized to DNA content. A) MSCs
exposed to IL-6 incubated at 37°C, B) MSCs exposed to IL-6 and heat shocked, C) MSCs exposed to
TNF-α incubated at 37°C, D) MSCs exposed to TNF-α and heat shocked. Error bars denote standard
deviation.

Calcium precipitation normalized to DNA at Day 28 was again much higher in the
osteogenic groups. There was a significant increase in calcium deposition in both the
control and IL-6 groups in osteogenic medium following heat shock (p < 0.0231) (Fig.
18B). In contrast, there was a significant decrease in calcium in the TNF-α group in
osteogenic medium following heat shock (p < 0.0026) (Fig. 18D). There was no
statistically significant difference in calcium content between MSCs cultured in growth
media following heat shock with the exception of a decrease in high-dose TNF-α (p =
0.0343) (Fig. 18D). Calcium deposition was also significantly higher in MSCs cultured
with TNF-α (both high and low-dose) in osteogenic media at 37°C (Fig. 18C).
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Figure 18. Colormetric assay for calcium measured at 28 days, normalized to DNA content. A) MSCs
exposed to IL-6 incubated at 37°C, B) MSCs exposed to IL-6 and heat shocked, C) MSCs exposed to
TNF-α incubated at 37°C, D) MSCs exposed to TNF-α and heat shocked. Error bars denote standard
deviation.

Figure 19 depicts the calcium data normalized to DNA as a function of time. Calcium
significantly decreased from 19 to 28 days in all growth media groups (p < 0.0166) with
the exception of MSCs exposed to low-dose TNF-α, which showed no significant
difference in calcium deposition (Fig. 19A). Calcium deposition significantly increased
from 19 to 28 days in all osteogenic conditions (p < 0.0031).
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Figure 19. Colormetric assay for calcium measured at 19 and 28 days, normalized to DNA content. A)
MSCs cultured in normal growth media at 37°C, B) MSCs cultured in growth media and heat shocked,
C) MSCs cultured in osteogenic media at 37°C, D) MSCs cultured in osteogenic media and heat
shocked. Error bars denote standard deviation.

35

IV. SUMMARY, DISCUSSION, AND FUTURE STUDIES
The

supplementation

of

growth

media

with

dexamethasone,

beta-

glycerophosphate, and ascorbic acid to promote the osteogenesis of MSCs is wellestablished54. The effects of periodic heat shock (39°C for 1 hour once per week) on
osteogenic differentiation of hMSCs during inflammation are herein investigated. Inhouse isolated hMSCs in osteogenic media formed mineralized aggregates by Day 12 in
2D culture (Figs. 4, 5, 6, 7). The effect was more pronounced among cells exposed to
TNF-α and heat. Mild heat shock was able to induce proliferation and significantly
mitigate the effects of TNF-α in the early days of differentiation (Fig. 3). Intracellular
ALP activity appears to significantly decrease in all conditions following heat shock at
Day 6 of the study (Fig. 11) and was mostly unaffected by heat shock at Day 12 (Fig. 12).
There was a significant dose-dependent response to TNF-α, however, increasing in
proportion to concentration (Figs. 8, 9, 11, 12). Changes in calcium content varied over
time and culture condition. Overall, calcium deposition was higher in osteogenic cultures.
Heat appeared to have minimal effect at Day 19 (Fig. 17). At Day 28, calcium increased
in the IL-6 group, but decreased in the TNF-α group compared to controls (Fig. 18). Still,
calcium deposition increased from 19 to 28 days in osteogenic media, but decreased in
growth media over the same period (Fig. 19).
It has previously been demonstrated that ALP activity, as well as calcium
deposition, in hMSCs is upregulated linearly with temperature48. ALP expression is a
dynamic process and its activity usually peaks between Day 9 and Day 12 during
osteogenesis, varying from donor to donor54. According to Shui et al., heat shock
expedites differentiation by shifting peak ALP activity earlier in the culture than
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normal48. Our findings show that intracellular ALP activity decreases with mild heating at
Day 6 (Fig. 11), contradictory to the established characteristics of intracellular ALP
activity in hMSCs. ALP activity was also shown to decrease in osteogenic conditions
from 6 to 12 days (Fig. 13), which may be a result of a shift in peak ALP activity closer
to Day 6 making ALP activity appear to decline from Days 6 to 12. ALP activity was also
shown to be sensitive to TNF-α, increasing linearly with concentration (Figs. 11, 12).
This data is validated by a previous study demonstrating that TNF-α upregulates ALP
activity and mineralization in hMSCs51.
Heat shock did induce earlier mineralization according to phase contrast images
(Figs. 4, 5). Because mineralization is a sign of osteogenic differentiation, these results
may have significance for bone regeneration in vivo. But it is important to note that
mineralization is not always a sign of osteogenic differentiation. Mineralization was
found to be higher around MSCs cultured with TNF-α (Fig. 5), a known inhibitor of
osteogenic differentiation55. Interestingly, ECM mineralization can occur as a result of
coexpression of Type I collagen and the enzyme TNAP, which can be upregulated by
inflammatory cytokines51,56. This seems a likely explanation for our findings.
Calcium assays performed on Days 19 and 28 yielded mixed results. Calcium
deposition by MSCs decreased or remained unchanged at Day 19 following heat shock
(Fig. 17). At Day 28, heat appears to increase calcium deposition in both controls and
cultures containing IL-6, but inhibits deposition in cultures containing TNF-α (Fig. 18).
As mentioned previously, calcium content has been known to increase in proportion to
mild heating48, contradicting our findings. TNF-α is known to inhibit osteogenic
differentiation and induce osteoblastic resorption, yet at Day 28, osteogenic cultures with
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TNF-α appear to have significantly more calcium compared to controls at 37°C (Fig.
18C). This may also be explained by the co-expression of Type I collagen and TNAP.
Von Kossa staining, often used to visualize mineralization, was significantly
darker in osteogenic cultures at Day 28 (Figs. 6 and 7), all of which showed significant
mineralization according to phase contrast images (Figs. 4 and 5) and calcium assays
(Fig. 15). Interestingly, von Kossa stains were noticeably darker after 28 days in two
unique conditions: MSCs cultured in normal growth media with 20ng/mL IL-6 at 37°C
and MSCs cultured in normal growth media with 1ng/mL TNF-α and heat shocked. These
results are notable since none of the other von Kossa stains of MSCs in normal growth
milieu displayed this degree of intensity. The results suggest heat inhibits mineral
deposition in MSCs cultured with high-dose IL-6 but promotes deposition in high-dose
TNF-α. However, it is important to note that, contrary to popular belief, the von Kossa
stain (silver nitrate) does not react with calcium but instead reacts with phosphate in the
presence of acidic material and therefore does not indicate the presence of calcium or
hydroxyapatite57.
Effects of mild hyperthermia on growth and proliferation during inflammation
were also studied. Heat generally appears to be more influential early in the culture than
later. Hyperthermia induced proliferation of MSCs in all culture conditions at Day 6, but
only control cultures were affected similarly at Day 12 (Fig. 3). By Day 28, proliferation
had significantly declined despite periodic heating. TNF-α significantly inhibits growth at
Days 6 and 12, which is consistent with what is known about the apoptotic effects of
TNF-α on MSCs58, but heat appears to mitigate this effect evidenced by higher DNA
content following heat shock at Day 6 (Figs. 1B and 1D). Overall, heat appears to inhibit
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cytokine-induced apoptosis during the early days of differentiation and promote
proliferation, potentially having a significant impact on future in vivo applications.
Future investigations will involve how we can translate our findings to develop a
practical heat-based therapy to be used in vivo. Hyperthermia is commonly applied to the
rehabilitation of musculoskeletal disorders, and our results suggest that it has potential to
mitigate inflammation and regenerate bone tissue. To effectively perform thermotherapy
on subchondral bone and the overlying articular cartilage, it is necessary to determine the
optimal intensity, duration, and interval of heat stimulation in humans. Hence, the effects
of varying heat conditions on the growth and differentiation of hMSCs during
inflammation must be studied.
Further contributing to the development of a thermotherapy for OA would be an
investigation into the effects of thermal pretreatment on hMSCs in vitro. Heat is often
used in preparation for open-heart surgery to upregulate chaperone proteins which
increases tolerance of the tissue to endangering situations during surgery such as
ischemia and hypoxia59. Exposing hMSCs to mild heating before simulating
inflammation by supplementing growth media with pro-inflammatory cytokines may
upregulate similar chaperone proteins and help protect cells from the inhibitory effect of
the cytokines. The role of heat shock proteins during differentiation under mild heating
should also be studied by utilizing siRNAs/shRNAs to silence expression of HSP70.
Lastly, our findings and those that came in previous studies necessitate the
development of a heat treatment delivery system mostly likely in the form of ultrasound.
It has already been shown that ultrasound promotes bone regeneration60. Ultrasound is
said to have anti-inflammatory properties and slow disease progression. Inflammation is a
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normal part of healing, but excessive, chronic inflammation is an issue. Uncontrolled
inflammation can delay healing61. Hashish et al show that ultrasound given in low doses
immediately after trauma lessens inflammation62, making ultrasound a promising
technology for future treatments needed suppresses inflammatory signals during
regeneration.
Ultrasound is known to mimic the effect of mechanical loading on bone
formation64. The effects of loading plus ultrasound were not significantly different from
ultrasound alone. Ultrasound is able to induce changes in bone that share at least some
features with mechanical loading, indicating that ultrasound exerts a similar influence on
bone as mechanical stimulation at a physiological level.
Additionally, MSCs can be induced to undergo chondrogenesis. Though we chose
to focus on an osteocentric model of OA in this study, a future thermotherapy design must
also be effective at regenerating articular cartilage. It is believed MSC differentiation is at
least in part mechanically regulated, and that the same signals used to optimize construct
growth may induce lineage-specific differentiation. Ultrasound may also induce
upregulation of aggrecan promoters, both structural components of cartilage. Aggrecan
promoter activity increased with increasing duration of loading in chondrocyte-laden
constructs. Aggrecan transcriptional activity increased after loading was applied to MSCladen constructs64. Physiological contact between two articulating layers of hyaline
cartilage generates mechanical signals within the tissue that act directly or indirectly on
the chondrocytes embedded within. Rapid dynamic unconfined compression increased
proteoglycan synthesis. Dynamic shearing of cartilage explants, which creates
deformation with little associated flow, increased collagen and proteoglycan synthesis
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uniformly65.
In summary, we studied the effects of heat shock on hMSC differentiation while
simulating inflammation in OA using IL-6 and TNF-α. Our results showed that periodic
mild heating induced proliferation of hMSCs and inhibited TNF-α-induced apoptosis.
ALP activity and calcium deposition were consistently higher in osteogenic cultures than
in normal growth media, but the effect of heat on these markers for osteogenesis was
mixed. The study will be repeated to confirm results, but the data presented here may
have a significant impact on the development of a therapeutic protocol for OA.
Hyperthermia represents a less invasive and simple therapy for clinical joint repairs, and
is thus a promising approach in bone and cartilage tissue engineering.
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VI. APPENDIX
1. Protocol for DNA Quantitation
1. Aspirate media and gently wash cells twice with 1X PBS.
2. Add 600µL of lysis buffer (0.5% Triton-X 100 in molecular grade ddH20) to each
well, then scrape the cells off the surface using the end of a pipette tip.
3. Transfer lysates to centrifuge tubes. Take 300µL of each lysate and transfer them
to a new set of tubes. Store everything in -20°C.
4. Thaw the second set of tubes, leaving the originals as backup. Add 75µL of
13.22mg/mL pepsin in 0.05N acetic acid to each lysate. Incubate at 2-8°C for 24
hours.
5. Add 75µL of pH=8.0 Tris buffer to each lysate to neutralize pepsin.
6. Centrifuge lysates at 0.1rcf for 5 minutes to pellet cell debris.
7. In triplicate, add 20µL of supernatant to a 96-well plate with 80μL of 1X TE
buffer diluted from the stock TE buffer provided in the Quant-iT™ PicoGreen ®
dsDNA Reagent kit.
8. Prepare a standard curve on the well plate by mixing the provided 2µg/mL DNA
standard with 1X TE buffer at the following concentrations: 5ng/mL, 40ng/mL,
100ng/mL, 250ng/mL, 500ng/mL, 1000ng/mL. Use 1X TE buffer as blank.
9. Prepare the fluorescent dye solution by diluting the provided dye 200 times with
1X TE buffer. Keep away from light.
10. Add 100µL of the dye solution to each well. Incubate away from light for 10
minutes.
11. Read the plate at excitation wavelength of 480nm and emission of 520nm.
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2. Protocol for ALP Activity Quantitation
1. Aspirate media and gently wash cells twice with 1X PBS.
2. Add 600µL of lysis buffer (0.5% Triton-X 100 in molecular grade ddH2O) to each
well, then scrape the cells off the surface using the end of a pipette tip.
3. Transfer lysates to centrifuge tubes. Prepare 15mL conical tubes equal to the
number of lysates.
4. Dissolve the contents of a 40mg capsule of Phosphatase Substrate in 10mL
ddH2O. Scale up if necessary.
5. Add 500µL of 1.5M Alkaline Buffer solution to each tube. Add 500µL of
Phosphatase Substrate solution into each tube. Keep tubes in 37°C water bath.
6. Vortex samples and add 100µL of each lysate to 15mL tubes in 30 second
intervals. Fifteen minutes after the first sample was added, add 1mL of 1N NaOH
to each tube in 30 second intervals removing tubes from water bath along the way.
This way, the reaction takes place for 15 minutes at 37°C for each tube.
7. Prepare standard curve according to the following chart:
Standard

Diluted pnitrophenol solution
(mL)

0.02N NaOH (mL)

Phosphatase Activity
(Sigma Units/mL)

1
2
3
4
5
6
7

0
1
2
4
6
8
10

300µL in well
10
9
7
5
3
1

0
1
2
4
6
8
10

8. Add 300uL of standards and samples in triplicate to a 96-well plate.
9. Measure the absorbance using excitation filter of 405nm.
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